Antipsychotics Blog Posts

• Behavioural and psychological symptoms of dementia: GPs’ perspective on management

  02 Oct 2018

  • Marie Crabbe

  
• Medical cannabis for mental illness: current use is not supported by research #MHQT

  24 Sep 2018

  • Luke Sheridan Rains

  
• Is Cannabidiol (CBD) an effective antipsychotic?

  24 Aug 2018

  • Luke Sheridan Rains

  
• Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

  13 Aug 2018

  • Elwira Lubos

  
• “Where I End And You Begin”: A personal commentary on Russo’s ‘Through the eyes of the observed’ #PsychDrugDebate

  24 Jul 2018

  • Sarah Carr

  
• How should we redirect research on psychiatric drugs? #PsychDrugDebate

  24 Jul 2018

  • Alison Faulkner

  
• Sexual function matters to people living with serious mental illness

  06 Jun 2018

  • Rudiger Pittrof
  • and Elana Covshoff

  
• Polypharmacy for major depression: is practice evidence-based?

  22 May 2018

  • Jessica Bone

  
• Understanding the genetics of antipsychotic treatment response

  30 Apr 2018

  • Marcus Munafo

  
• Improving outcomes for people with first episode psychosis

  19 Apr 2018

  • Elwira Lubos